Daridorexant Hydrochloride Tablets Research: CAGR of 29.8% during the forecast period

QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Daridorexant Hydrochloride Tablets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Daridorexant Hydrochloride Tablets market, including market size, share, demand, industry development status, and forecasts for the next few years.

The global market for Daridorexant Hydrochloride Tablets was estimated to be worth US$ 69.19 million in 2024 and is forecast to a readjusted size of US$ 831 million by 2031 with a CAGR of 29.8% during the forecast period 2025-2031.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5485183/daridorexant-hydrochloride-tablets

Daridorexant Hydrochloride Tablets Market Summary

Daridorexant hydrochloride represents a pivotal advancement within the class of dual orexin receptor antagonists, offering a shift from sedative-hypnotic intervention toward true modulation of the sleep-wake regulatory system. Its optimized pharmacokinetic profile, including an intermediate half-life and rapid onset, supports effective nighttime symptom control while reducing next-day impairment. The drug has developed strong international clinical recognition following approvals across major markets, supported by robust evidence demonstrating improvements in both sleep continuity and daytime functioning. Its differentiation from traditional hypnotics-particularly regarding dependence risk, preservation of sleep architecture, and tolerability-has positioned it as a leading option within mechanism-based insomnia therapies.

In practice, the product has been increasingly adopted across sleep clinics, psychiatric settings, and primary care environments. Its clinical value is especially emphasized for adults with chronic insomnia, nighttime awakenings, and those who seek an alternative to benzodiazepine or Z-drug therapies. Growing real-world evidence has enhanced understanding of its long-term safety, pharmacological interactions, and suitability for older adults or patients with comorbid anxiety or mood disorders. Market penetration has been supported by comprehensive patient-education programs, pharmacist involvement, and digital tools that help track treatment outcomes, contributing to broader acceptance and adherence.

Looking ahead, daridorexant is well positioned to expand its therapeutic footprint as global awareness of sleep-health importance continues to rise. Potential future indications under investigation include insomnia associated with anxiety, neurodegenerative disorders, postoperative sleep disruption, and chronic pain-related sleep disturbances. Continued innovation in formulation science, personalized dosing strategies, and longitudinal cohort research will likely strengthen its role in clinical guidelines. As regulatory agencies in emerging markets increasingly support mechanism-innovative therapies and as global supply chains mature, the product is expected to achieve wider international commercialization and maintain its leading role in shaping the development trajectory of DORA-based insomnia treatments.

According to the new market research report "Global Daridorexant Hydrochloride Tablets Market Report 2024-2030", published by QYResearch, the global Daridorexant Hydrochloride Tablets market size is projected to grow from USD 69 million in 2024 to USD 831 million by 2031, at a CAGR of 29.8% during the forecast period.

The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.

The Daridorexant Hydrochloride Tablets market is segmented as below:
By Company
Idorsia
Simcere Pharmaceutical
Nxera Pharma

Segment by Type
25mg
50 mg

Segment by Application
Hospital and Clinic
Retail Pharmacies
Other

Each chapter of the report provides detailed information for readers to further understand the Daridorexant Hydrochloride Tablets market:

Chapter 1: Introduces the report scope of the Daridorexant Hydrochloride Tablets report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2021-2032)
Chapter 2: Detailed analysis of Daridorexant Hydrochloride Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2021-2026)
Chapter 3: Provides the analysis of various Daridorexant Hydrochloride Tablets market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2021-2032)
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2021-2032)
Chapter 5: Sales, revenue of Daridorexant Hydrochloride Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2021-2032)
Chapter 6: Sales, revenue of Daridorexant Hydrochloride Tablets in country level. It provides sigmate data by Type, and by Application for each country/region.(2021-2032)
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2021-2026)
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Benefits of purchasing QYResearch report:

Competitive Analysis: QYResearch provides in-depth Daridorexant Hydrochloride Tablets competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge.

Industry Analysis: QYResearch provides Daridorexant Hydrochloride Tablets comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis.

and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions.

Market Size: QYResearch provides Daridorexant Hydrochloride Tablets market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development.

Other relevant reports of QYResearch:
Global Daridorexant Hydrochloride Tablets Market Research Report 2025
Global Daridorexant Hydrochloride Tablets Market Outlook, In‐Depth Analysis & Forecast to 2031
Global Daridorexant Hydrochloride Tablets Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

About Us:
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 19 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp

This release was published on openPR.